Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
Pavlů, J Labopin, M Zoellner, A Sakellari, I Stelljes, M Finke, J Fanin, R Stuhler, G Afanasyev, B Bloor, Adrian
Pavlů, J
Labopin, M
Zoellner, A
Sakellari, I
Stelljes, M
Finke, J
Fanin, R
Stuhler, G
Afanasyev, B
Bloor, Adrian
Citations
Altmetric:
Abstract
Patients with primary refractory acute lymphoblastic leukemia (PREF ALL) who fail to achieve a complete remission (CR) after ≥2 courses of chemotherapy have a dismal prognosis without undergoing allogeneic hematopoietic cell transplantation (HCT). To the authors' knowledge, there currently are no data regarding factors influencing transplantation outcomes.
Description
Date
2017-02-17
Publisher
Collections
Keywords
Type
Article
Citation
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT. 2017 Cancer